Indoleamine 2,3-Dioxygenase and Dendritic Cell Tolerogenicity

REFERENCES

• Baban, B., Hansen, A. M., Chandler, P. R., Manlapat, A., Bingaman, A., Kahler, D. J., Munn, D. H., Mellor, A. L. (2005). A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Int. Immunol. 17:909–919.
   PubMed Web of Science ®Google Scholar
• Baban, B., Chandler, P. R., Sharma, M. D., Pihkala, J., Koni, P. A., Munn, D. H., Mellor, A. L. (2009). IDO activates regulatory T cells and block their conversion into Th17-like T cells. J. Immunol. 183(4):2475–2483.
   PubMed Web of Science ®Google Scholar
• Baban, B., Chandler, P. R., Johnson, B. A., III, Huang, L., Li, M., Sharpe, M. L., Francisco, L. M., Sharpe, A. H., Blazar, B. R., Munn, D. H., Mellor, A. L. (2011). Physiologic Control of IDO Competence in Splenic Dendritic Cells. J. Immunol. 187: 2329–2335.
   PubMed Web of Science ®Google Scholar
• Belladonna, M. L., Volpi, C., Bianchi, R., Vacca, C., Orabona, C., Pallotta, M. T., Boon, L., Gizzi, S., Fioretti, M. C., Grohmann, U., Puccetti, P. (2008). Cutting edge: Autocrine TGF-{beta} sustains default tolerogenesis by IDO-competent dendritic cells. J. Immunol. 181:5194–5198
   PubMed Web of Science ®Google Scholar
• Belladonna, M. L., Orabona, C., Grohmann, U., Puccetti, P. (2009). TGF-beta and kynurenine as the key to infectious tolerance. Trends Mol Med. 15(2):41–49.
   PubMed Web of Science ®Google Scholar
• Benson, J. M., Shepherd, D. M. (2011). Dietary ligands of the aryl hydrocarbon receptor induce anti-inflammatory and immunoregulatoy effect on murine dendritic cells. Toxicol. Sci. 124(2):327–338.
   PubMed Web of Science ®Google Scholar
• Boasso, A., Royle, C. M., Doumazos, S., Aquino, V. N., Biasin, M., Piacentini, L., Tavano, B., Fuchs, D., Mazzotta, F., Lo Caputo, S., Shearer, G. M., Clerici, M., Graham, D. R. (2011). Overactivation of plasamacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis. Blood 118(19):5152–5162.
   PubMed Web of Science ®Google Scholar
• Brenk, M., Scheler, M., Koch, S., Neumann, J., Takikawa, O., Hacker, G., Bieber, T., von Bubnoff, D. (2009). Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells. J. Immunol. 183(1):145–154.
   PubMed Web of Science ®Google Scholar
• Buckwalter, M. R., Albert, M. L. (2009). Orchestration of the immune response by dendritic cells. Curr. Biol. 19(9):355–361.
   Web of Science ®Google Scholar
• Chen, W. J. (2011). IDO: more than an enzyme. Nat. Immunol. 12(9): 809–811.
   PubMed Web of Science ®Google Scholar
• Choi, B. K., Kim, Y. H., Choi, J. H., Kim, C. H., Kim, K. S., Sung, Y. C., Lee, Y. M., Moffett, J. R., Kwon, B. S. (2011). Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivo. Cytokine 55(3): 420–428.
   PubMed Web of Science ®Google Scholar
• Chung, D. J., Rossi, M., Romano, E., Ghith, J., Yuan, J., Munn, D. H., Young, J. W. (2009). Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 114(3):555–563.
   PubMed Web of Science ®Google Scholar
• Coombes, J. L., Siddiqui, K. R., Arancibia-Carcamo, C. V., Hall, J., Sun, C. M., Belkaid, Y., Powrie, F. (2007). A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204(8):1757–1764.
   PubMed Web of Science ®Google Scholar
• Daissormont, I. T., Christ, A., Temmerman, L., Sampedro Millares, S., Seijkens, T., Rousch, M., Poggi, M., Boon, L., van der Loos, C., Daemen, M., Lutgens E, Halvorsen B, Aukrush P, Janssen E, Biessen EA. (2011). Plasmacytoid dendritic cells protect against atheroslerosis by tuning T-cell proliferation and activity. Circ. Res. 109(12): 1387–1395.
   PubMed Web of Science ®Google Scholar
• den Haan, J. M. M., Lehar, S. M., Bevan, M. J. (2000). Cd8+ but not CD8- dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192(12):1685–1696.
   PubMed Web of Science ®Google Scholar
• de Souze Sales, J., Lara, F. A., Amadeu, T. P., de Oliveira Fulco, T., da Costa Nery, J. A., Sampaio, E. P., Pinheiro, R. O., Sarno, E. N. (2011). The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression. Clin. Exp. Immunol. 165(2):251–263.
   PubMed Web of Science ®Google Scholar
• Dong, C. (2008). TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8:337–348.
   PubMed Web of Science ®Google Scholar
• Egilmez, N. K., Kilinc, M. O., Gu, T., Conway, T. F. (2007). Controlled-release particulate cytokine adjuvants for cancer therapy. Endocr. Metab. Imm. Disord. Drug Targets 7(4):266–270.
   PubMedGoogle Scholar
• Fallarino, F., Vacca, C., Orabona, C., Belladonna, M. L., Bianchi, R., Marshall, B., Keskin, D. B., Mellor, A. L., Fioretti, M. C., Grohmann, U., Puccetti, P. (2002). Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. Int. Immunol. 14(1):65–68.
   PubMed Web of Science ®Google Scholar
• Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M. L., Puccetti, P. (2003). Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4(12):1206–1212.
   PubMed Web of Science ®Google Scholar
• Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., Santamaria, P., Fioretti, M., Puccetti, P. (2006). The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell Receptor {zeta}-chain and induce a regulatory phenotype in naïve T cells. J. Immunol. 176:6752–6761.
   PubMed Web of Science ®Google Scholar
• Favre, D., Mold, J., Hunt, P. W., Kanwar, B., Loke, P., Seu, L., Barbour, J. D., Lowe, M. M., Jayawardene, A., Aweeka, F., Huang, Y., Douek, D. C., Brenchley, J. M., Martin, J. N., Hecht, F. M., Deeks, S. G., McCune, J. M. (2010). Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med. 2(32):32–36.
   Web of Science ®Google Scholar
• Flatekval, G. F., Sioud, M. (2009). Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase. Immunology 128:837–848.
   PubMed Web of Science ®Google Scholar
• Forouzandeh, F., Jalili, R. B., Germain, M., Duronio, V., Ghahary, A. (2008). Skin cells, but not T cells, are resistant to indoleamine 2,3-dioxygenase (IDO) expressed by allogenic fibroblasts. Wound Repair Regen. 16:379–387.
   PubMed Web of Science ®Google Scholar
• Fricke, I., Gabrilovich, D. I. (2006). Dendritic cells and tumor microenvironment: A dangerous liaison. Immunol. Investig. 35:459–483.
   PubMed Web of Science ®Google Scholar
• Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., Ferrara GB. (2002). Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196(4):459–468.
   PubMed Web of Science ®Google Scholar
• Granucci, F., Zanoni, I. (2009). The dendritic cell life cycle. Cell Cycle 8(23):3816–3821.
   PubMed Web of Science ®Google Scholar
• Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., Puccetti, P. (2002). CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3(11):1097–1-101
   PubMed Web of Science ®Google Scholar
• Grohmann, U., Fallarino, F., Bianchi, R., Orabona, C., Vacca, C., Fioretti, M. C., Puccetti, P. (2003a). A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J. Exp. Med. 198(1):153–160.
   PubMed Web of Science ®Google Scholar
• Grohmann, U., Bianchi, R., Orabona, C., Fallarino, F., Vacca, C., Micheletti, A., Fioretti, M. C., Puccetti, P. (2003b). Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. J. Immunol. 171:2581–2587.
   PubMed Web of Science ®Google Scholar
• Gu, T., Rowswell-Turner, R. B., Kilinc, M. O., Egilmez, N. K. (2010). Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity. Cancer Res. 70(1):129–138.
   PubMed Web of Science ®Google Scholar
• Habibi, D., Jalili, R. B., Forouzandeh, F., Ong, C. J., Ghahary, A. (2010). High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death. J. Cell. Physiol. 225:196–205.
   PubMed Web of Science ®Google Scholar
• Harden, J. L., Gu, T., Kilinc, M. O., Rowswell-Turner, R. B., Virtuoso, L. P., Egilmez, N. K. (2011). Dichotomous effects of IFN-{gamma} on dendritic cell function determine the extent of IL-12-driven antitumor T cell immunity. J. Immunol. 187(1):126–132.
   PubMed Web of Science ®Google Scholar
• Heath, W. R., Carbone, F. R. (2009). Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10(12):1237–1244.
   Google Scholar
• Heller MC, Drew CP, Jackson KA, Griffey S, Watson JL. (2010). A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection. Vet. Immunol. Immunopathol. 138(3):174–82
   PubMed Web of Science ®Google Scholar
• Hoshi, M., Saito, K., Hara, A., Taguchi, A., Ohtaki, H., Tanaka, R., Fujigaki, H., Osawa, Y., Takemura, M., Matsunami, H., Ito, H., Seishima, M. (2010).The absence of IDO up-regulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse. J. Immunol. 185(6):3305–3312.
   PubMed Web of Science ®Google Scholar
• Hou, D., Muller, A. J., Sharma, M. D., DuHadaway, J., Banerjee, T., Johnson, M., Mellor, A. L., Prendergast, G. C., Munn, D. H. (2007). Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res. 67(2):792–801.
   PubMed Web of Science ®Google Scholar
• Huang, T. T., Yen, M. C., Lin, C. C., Weng, T. Y., Chen, Y. L., Lin, C. M., Lai, M. D. (2011). Skin delivery of short hairpin RNA of indoleamine 2,3-dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer. Cancer Sci. 102(12): 2214–2220.
   PubMed Web of Science ®Google Scholar
• Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA. (2000). Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164(7): 3596–3599.
   PubMed Web of Science ®Google Scholar
• Jasperson, L. K., Bucher, C., Panoskaltsis-Mortari, A., Mellor, A.L., Munn, D.H., Blazar, B.R. (2009). Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. Blood 114(24):5062–5070.
   PubMed Web of Science ®Google Scholar
• Johnson, B. A., III, Baban, B., Mellor, A. L. (2009). Targeting the immunoregulatory indoleamine 2,3-dioxygenase pathway in immunotherapy. Immunotherapy. 1(4):645–661.
   PubMed Web of Science ®Google Scholar
• Johnson, B. A., III, Kahler, D. J., Baban, B., Chandler, P. R., Kang, B., Shimoda, M., Koni, P. A., Pihkala, J., Vilagos, B., Busslinger, M., . (2010). B-lymphoid cells with attributes of dendritic cells regulate T cells via indolaemine 2,3-dioxygenase. Proc. Natl. Acad. Sci. USA 107:10644–10648.
   PubMed Web of Science ®Google Scholar
• Jurgens, B., Hainz, U., Fuchs, D., Felzmann, T., Heitger, A. (2009). Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogenic T cells. Blood 114(15):3235–3243.
   PubMed Web of Science ®Google Scholar
• Kamath, A. T., Henri, S., Battye, F., Tough, D. F., Shortman, K. (2002). Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100(5):1734–1741.
   PubMed Web of Science ®Google Scholar
• Kammerer, U., Kruse, A., Barrientos, G., Arck, P. C., Blois, S.M. (2008). Role of dendritic cells in the regulation of maternal immune responses to the fetus during mammalian gestation. Immunol. Invest. 37:499–533.
   PubMed Web of Science ®Google Scholar
• Kilinc, M. O., Aulakh, K. S., Nair, R. E., Jones, S. A., Alard, P., Kosiewicz, M. M., Egilmez, N. K. (2006). Reversing tumor immune suppression with intratumoral IL-12: activationof tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effects. J. Immunol. 177(10):6962–6973.
   PubMed Web of Science ®Google Scholar
• Kilinc, M. O., Rowswell-Turner, R. B., Gu, T., Virtuoso, L. P., Egilmez, N. K. (2009). Activated CD8+ T-effector/memory cells eliminate CD4+ CD25+ Foxp3+ T-suppressor cells from tumors via FasL mediated apoptosis. J. Immunol. 183(12): 7656–7660.
   PubMed Web of Science ®Google Scholar
• Kilinc, M. O., Gu, T., Harden, J. L., Virtuoso, L. P., Egilmez, N. K. (2009). Central role of tumor-associated CD8+ T-ceffector/memory cells in restoring systemic antitumor immunity. J. Immunol. 182(7):4217–4225.
   PubMed Web of Science ®Google Scholar
• Kuales, M. A., Wenzel, J., Schmid-Wendtner, M. H., Bieber, T., von Bubnoff, D. (2011). Myeloid CD11c+ S100+ dendritic cells express indoleamine 2,3-dioxygenase at the inflammatory border to invasive lower lip squamous cell carcinoma. Histol. Histopathol. 8: 997–1006.
   Google Scholar
• Laskarin G, Kammerer U, Rukavina D, Thomson AW, Fernandez N, Blois SM. (2007). Antigen-presenting cells and materno-fetal tolerance: an emerging role for dendritic cells. Am. J. Reprod. Immunol. 68(3):255–267.
   Google Scholar
• Lee, J. H., Chen, Y., Chan, J. L., Qian, Y. W., Goydos, J. S. (2011). Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction. Cancer Immunol. Immunother. 60(5):685–692.
   PubMed Web of Science ®Google Scholar
• Li, W., Li, B., Fan, W., Geng, L., Li, X., Li, L., Huang, Z., Li, S. (2009). CTLA4Ig gene transfer alleviates abortion in mice by expanding CD4+CD25+ regulatory T cells and inducing indoleamine 2,3-dioxygenase. J. Reprod. Immunol. 80(1–2):1–11.
   PubMed Web of Science ®Google Scholar
• Lipscomb, M. W., Taylor, J. L., Goldbach, C. J., Watkins, S. C., Wesa, A. K., Storkus, W. J. (2010). DC expressing transgene Foxp3 are regulatory APC. Eur. J. Immunol. 40(2):480–493.
   PubMed Web of Science ®Google Scholar
• Liu, X., Shin, N., Koblish, H. K., Yang, G., Wang, Q., Wang, K., Leffet, L., Hansbury, M. J., Thomas, B., Rupar, M., Waeltz, P., Bowman, K. J., Polam, P., Sparks, R. B., Yue, E. W., Li, Y., Wynn, R., Fridman, J. S., Burn, T. C., Combs, A. P., Newton, R. C., Scherle, P. A. (2010). Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. Blood 115(17): 3520–3530.
   PubMed Web of Science ®Google Scholar
• Lu, Y., Giver, C. R., Sharma, A., Li, J. M., Darlak, K. A., Owen, L. M., Roback, J. D., Galipeau, J., Wller, E. K. (2012). Interferon-gamma and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity. Blood 119(4):1075–1085.
   PubMed Web of Science ®Google Scholar
• MacDonald, T. T., Monteleone, I., Fantini, M. C., Monteleone, G. (2011). Regulation of homeostasis and inflammation in the intestine. Gastroenterology 140(6):1768–1775.
   PubMed Web of Science ®Google Scholar
• Maldonado-Lopez, R., De Smedt, T., Michel, P., Godfroid, J., Pajak, B., Heirman, C., Thielemans, K., Leo, O., Urbain, J., Moser, M. (1999). CD8{alpha}+ and CD8{alpha}- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189(3)587–592.
   PubMed Web of Science ®Google Scholar
• Manlapat, A. K., Kahler, D. J., Chandler, P. R., Munn, D. H., Mellor, A. L. (2007). Cell-autonomous contol of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells. Eur. J. Immunol. 37(4):1064–1071.
   PubMed Web of Science ®Google Scholar
• Matteoli, G., Mazzini, E., Iliev, I. D., Mileti, E., Fallarino, F., Puccetti, P., Chieppa, M., Rescigno, M. (2010). Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/ T effector cell balance and oral tolerance induction. Gut 56:595–604.
   Google Scholar
• Mellor, A. L., Keskin, D. B., Johnson, T., Chandler, P., Munn, D. H. (2002). Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J. Immunol. 168:3771–3776.
   PubMed Web of Science ®Google Scholar
• Mellor, A. L., Chandler, P., Baban, B., Hansen, A. M., Marshall, B., Pihkala, J., Waldmann, H., Cobbold, S., Adams, E., Munn, D. H. (2004). Specific subsets of murine dendritic cells acquire potent T-cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3-dioxygenase. Int. Immunol. 16(10):1391–1401.
   PubMed Web of Science ®Google Scholar
• Mellor, A. L., Baban, B., Chandler, P. R., Manlapat, A., Kahler, D. J., Munn, D. H. (2005). Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to aquire potent indoleamine 2,3-dioxygenase-dependent T-cell regulatory functions via IFN type I signaling. J. Immunol. 175:5601–5605.
   PubMed Web of Science ®Google Scholar
• Mellor, A. L. (2005). Indoleamine 2,3-dioxygenase and regulation of T cell immunity. Biochem. Biophys. Res. Commun. 338(1):20–24.
   PubMed Web of Science ®Google Scholar
• Mezrich, J. D., Fechner, J. H., Zhang, X., Johnson, B. P., Burlingham, W. J., Bradfield, C. A. (2010). An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185(6): 3190–3198.
   PubMed Web of Science ®Google Scholar
• Muller, A. J., Heseler, K., Schmidt, S. K., Spekker, K., Mackenzie, C. R., Daubener, W. (2009). The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects. J. Cell Mol. Med. 13(6):1125–1135.
   PubMed Web of Science ®Google Scholar
• Muller, A. J., Sharma, M. D., Chandler, P. R., DuHadaway, J. B., Everhart, M. E., Johnson, B. A., III, Kahler, D. J., Pihkala, J., Soler, A. P., Munn, D. H. (2008). Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3-dioxygenase. Proc. Net. Acad. Sci. USA 105(44):17073–17078.
   Google Scholar
• Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., Mellor, A. L. (1998). Prevention of allogenic fetal rejection by tryptophan catabolism. Science 281(5380):1191–1193.
   PubMed Web of Science ®Google Scholar
• Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., Mellor, A. L. (2004). Expression of indoleamine 2,3-dioxygenase by Plasmacytoid dendritic cells in tumor-draining lymph nodes. J. Clin. Invest. 114(2):280–290.
   PubMed Web of Science ®Google Scholar
• Munn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D., Mellor, A. L. (2005). GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22(5):633–642.
   PubMed Web of Science ®Google Scholar
• Munn, D. H. (2010). Lineage-specific transcription factors in unexpected places. Eur. J. Immunol. 40(2):315–317.
   PubMed Web of Science ®Google Scholar
• Nair, J. R., Carlson, L. M., Koorelle, C., Rozanski, C. H., Byrne, G. E., Bergsagel, P. L., Shaughnessy, J. P. Jr., Boise, L. H., Chana-Khan, A., Lee, K. P. (2011). CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment. J. Immunol. 187(3):1243–1253.
   PubMed Web of Science ®Google Scholar
• Nair, R. E., Kilinc, M. O., Jones, S. A., Egilmez, N. K. (2006). Chronic immune therapy induces a progressive increase in intratumoral T suppressor activity and a concurrent loss of tumor-specific CD8+ T-effects in her-2/neu transgenic mice bearing advanced spontaneous tumors. J. Immunol. 176(12):7325–7334.
   PubMed Web of Science ®Google Scholar
• Nguyen, N. T., Kimura, A., Nakahama, T., Chinen, I., Masuda, K., Nohara, K., Fujii-Kuriyama, Y., Kishimoto, T. (2010). Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Nat. Acad. Sci. USA 107(46):19961–19966.
   PubMed Web of Science ®Google Scholar
• Njau, F., Geffers, R., Thalmann, J., Haller, H., Wagner, A. D. (2009). Restriction of Chlamydia pneumoniae replication in human dendritic cell by activation of indoleamine 2,3-dioxygenase. Microbes Infect. 11(13):1002–1010.
   PubMed Web of Science ®Google Scholar
• Norian, L. A., Rodriquez, P. C., O’Mara, L. A., Zabaleta, J., Ochoa, A. C., Cella, M., Allen, P. M. (2009). Tumor-infiltrating regulatoy dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res. 69(7):3086.
   PubMed Web of Science ®Google Scholar
• O’Sullivan, B. J., Pai, S., Street, S., An, X., MacDonald, K. P., Wong, M., Strutton, G., Gerondakis, S, Steptoe RJ, de St Groth BF, Hill GR, Thomas R. (2011). Immunotherapy with costimulatory dendritic cells to control autoimmune inflammation. J. Immunol. 187(8):4018–4030.
   PubMed Web of Science ®Google Scholar
• Ochiel, D. O., Ghosh, M., Fahey, J. V., Guyre, P. M., Wira, C. R. (2010). Human uterine epithelial cell secretions regulate dendritic cells differentiation and responses to TLR ligands. J. Leukoc. Biol. 88(3):435–444.
   PubMed Web of Science ®Google Scholar
• Onodera, T., Jang, M. H., Guo, Z., Yamasaki, M., Hirata, T., Bai, Z., Tsuji, N. M., Nagakubo, D., Yoshie, O., Sakaguchi, S., Takikawa, O., Miyasaka, M. (2009). Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions. J. Immunol. 183(9): 5608–5614.
   PubMed Web of Science ®Google Scholar
• Orabona, C., Grohmann, U., Belladonna, M. L., Fallarino, F., Vacca, C., Bianchi, R., Bozza, S., Volpi, C., Salomon, B. L., Fioretti, M. C., Romani, L., Puccetti, P. (2004). CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol. 5(11):1134–1142.
   PubMed Web of Science ®Google Scholar
• Ou, X., Cai, S., Liu, P., Zeng, J., He, Y., Wu, X., Du, J. (2008). Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT. J. Cancer. Res. Clin. Oncol. 134(5):525–533.
   PubMed Web of Science ®Google Scholar
• Pallotta, M. T., Orabona, C., Volpi, C., Vacca, C., Belladonna, M. L., Bianchi, R., Servillo, G., Brunacci, C., Calvitti, M., Bicciato, S., Mazza, E. M., Boon, L., Grassi, F., Fioretti, M. C., Fallarino, F., Puccetti, P., Grohmann U. (2011). Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat. Immunol. 12(9):870–878.
   PubMed Web of Science ®Google Scholar
• Quintana, F. J., Murugaiyan, G., Farez, M. F., Mitsdoerffer, M., Tukpah, Burns, E. J., Weiner, H. L. (2010). An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc. Nat. Acad. Sci. USA 107(48):20768–20773.
   PubMed Web of Science ®Google Scholar
• Reizis, B., Colonna, M., Trinchieri, G., Barat, F., Gilliet, M. (2011). Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat. Rev. Immunol. 11:558–565.
   PubMed Web of Science ®Google Scholar
• Sharma, M. D., Hou, D. Y., Koni, P. A., Metz, R., Chandler, P., Mellor, A. L., He, Y., Munn, D. H. (2009). Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 113(24):6102–6111.
   PubMed Web of Science ®Google Scholar
• Simones, T., Shepherd, D. M. (2011). Consequences of AhR activation in steady-state dendritic cells. Toxicol. Sci. 119(2): 293–307.
   PubMed Web of Science ®Google Scholar
• Smith, A. J., Toledo, C. M., Wietgrefe, S. W., Duan, L., Schacker, T. W., Reilly, C. S., Haase, A. T. (2011).The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection. J. Immunol. 186(11): 6576–6584.
   PubMed Web of Science ®Google Scholar
• Soliman, H., Mediaville-Varela, M., Antonia, S. (2010). Indoleamine 2,3-Dioxygenase – Is It an Immun Suppressor? Cancer J. 16:354–359.
   PubMed Web of Science ®Google Scholar
• Steinman, R. M., Cohn, Z. A. (1973). Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137(5):1142–1162.
   PubMed Web of Science ®Google Scholar
• Stockinger, B., Hirota, K., Duarte, J., Veldhoen, M. (2011). External influences on the immune system via activation of the aryl hydrocarbon receptor. Semin. Immunol. 23(2):99–105.
   PubMed Web of Science ®Google Scholar
• Sucher, R., Fischler, K., Oberhuber, R., Kronberger, I., Margreiter, C., Ollinger, R., Schneeberger, S., Fuchs, D., Werner, E. R., Watschinger, K., Zelger, B., Tellides, G., Pilat, N., Pratschke, J., Margreiter, R., Wekerle, T,. Brandacher, G. (2012). IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival. J. Immunol. 188(1):37–46.
   PubMed Web of Science ®Google Scholar
• Sun, C. M., Hall, J. A., Blank, R. B., Bouladoux, N., Oukka, M., Mora, J. R., Belkaid, Y. (2007). Small interstine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204(8):1775–1785.
   PubMed Web of Science ®Google Scholar
• Sun, Y., Chin, Y. E., Weisiger, E., Malter, C., Tawara, I., Toubai, T., Gatza, E., Mascagni, P., Dinarello, C. A., Reddy, P. (2009). Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3. J. Immunol. 182(10):5899–5903.
   PubMed Web of Science ®Google Scholar
• Terness, P., Bauer, T. M., Rose, L., Dufter, C., Watzlik, A., Simon, H., Opelz, G. (2002). Inhibition of Allogenic T Cell Proliferation by Indoleamine 2,3-Dioxygenase-expressing Dendritic Cells: Mediation of Suppression by Tryptophan Metabolites. J. Exp. Med. 196(4):447–457.
   PubMed Web of Science ®Google Scholar
• Tsampalas, M., Gridelet, V., Berndt, S., Foidart, J. M., Geenen, V., Perrier d’Hauterive, S. (2010). Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. J. Reprod. Immunol. 85(1): 93–8
   PubMed Web of Science ®Google Scholar
• Veldhoen, M., Duarte, J. H. (2010). The aryl hydrocarbon receptor: fine-tuning the immune-response. Curr. Opin. Immunol. 22(6):747–752.
   PubMed Web of Science ®Google Scholar
• Wallet, M. A., Sen, P., Tisch, R. (2005). Immunoregulation of dendritic cells. Clin. Med. Res. 3(3):166–175.
   PubMedGoogle Scholar
• Wan, H., Versnel, M. A., Leijten, L. M., van Helden-Meeuwsen, C. G., Fekkes, D., Leenen, P. J., Khan, N. A., Benner, R., Kiekens, R. C.(2008). Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype. J. Leukoc. Biol. 83(4):894–901.
   PubMed Web of Science ®Google Scholar
• Watkins, S. K., Zhu, Z., Riboldi, E., Shafer-Weaver, K. A., Stagliano, K. E., Sklavos, M. M., Ambs, S., Yagita, H., Hurwitz, A. A. (2011). FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J. Clin. Invest. 121(4):1361–1372.
   PubMed Web of Science ®Google Scholar
• Wobser, M., Voigt, H., Houben, R., Eggert, A. O., Freiwald, M., Kaemmerer, U., Kaempgen E, Schrama D, Becker JC. (2007). Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression. Cancer Immunol. Immunother. 56(7): 1017–24
   PubMed Web of Science ®Google Scholar
• Yan, Y., Zhang, G. X., Gran, B., Fallarino, F., Yu, S., Li, H., Cullimore, M. L., Rostami, A., Xu, H. (2010). IDO up-regulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encepthalomyelitis. J. Immunol. 185(10): 5953–5961.
   PubMed Web of Science ®Google Scholar
• Yang, H. J., Yen, M. C., Lin, C. C., Lin, C. M., Chen, Y. L., Weng, T. Y., Huang, T. T., Wu, C. L., Lai, M. D. (2010). A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity. Exp. Biol. Med. Maywood). 235(7): 869–876.
   PubMed Web of Science ®Google Scholar
• Yen, M. C., Lin, C. C., Chen, Y. L., Huang, S. S., Yang, H. J., Chang, C. P., Lei, H. Y., Lai, M. D. (2009). A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA. Clin. Cancer Res. 15(2):641–649.
   PubMed Web of Science ®Google Scholar
• Zhang, T., Fresney, S., Welty, E., Sangrampukar, N., Rybak, E., Zhou, H., Cheng, X. F., Feng, Q., Avon, C., Laaris, A., Whitters, M., Nagelin, A. M., O’Hara, R. M. Jr., Azimzadeh, A. M. (2011). Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner. Am. J. Transplant. 11(8):1599–1609.
   PubMed Web of Science ®Google Scholar
• Zhu, B. T. (2010). Development of selective immune tolerance towards the allogenic fetus during pregnancy: Role of tryptophan catabolites. Int. J. Mol. Med. 25:831–835.
   PubMed Web of Science ®Google Scholar